Author:
Johnson Matthew B.,Cerosaletti Karen,Flanagan Sarah E.,Buckner Jane H.
Funder
National Institutes of Health
Wellcome Trust
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference85 articles.
1. Bottazzo GF, Florin-Christensen A, Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet (London, England) [Internet]. 1974 Nov 30 [cited 2019 Jan 4];2(7892):1279–83. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/4139522
2. •• Onengut-Gumuscu S, Chen W-M, Burren O, Cooper NJ, Quinlan AR, Mychaleckyj JC, et al. Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers. Nat Genet [Internet]. 2015 Apr 9 [cited 2019 Jan 4];47(4):381–6. Available from:
http://www.nature.com/articles/ng.3245
. Fine-mapped susceptibility loci in T1D and showed that T1D was more genetically similar to antibody-driven autoimmune diseases than non-antibody-associated.
3. Barrett JC, Clayton DG, Concannon P, Akolkar B, Cooper JD, Erlich HA, et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet [Internet]. 2009 Jun 10 [cited 2019 Jan 4];41(6):703–7. Available from:
http://www.nature.com/articles/ng.381
4. Andlauer TFM, Buck D, Antony G, Bayas A, Bechmann L, Berthele A, et al. Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation. Sci Adv [Internet]. 2016 Jun [cited 2019 Jan 30];2(6):e1501678. Available from:
https://doi.org/10.1126/sciadv.1501678
5. Erlich H, Valdes AM, Noble J, Carlson JA, Varney M, Concannon P, et al. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes [Internet]. 2008 Apr 1 [cited 2019 Jan 8];57(4):1084–92. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/18252895
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献